Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn M March

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Calcified Tissue International|November 26, 2010
Contribution of a common variant in the promoter of the 1-α-hydroxylase gene (CYP27B1) to fracture risk in the elderlyRoderick J Clifton-Bligh, Tuan V Nguyen, Amy Au, et al.
Age and Ageing|July 10, 2003
Proxy assessment of health-related quality of life in the frail elderlyYih Yiow Sitoh, Tang Ching Lau, Jane Zochling, et al.
Journal of the American Geriatrics Society|August 5, 2005
Atypical antipsychotic medications and risk of falls in residents of aged care facilitiesLe T T Hien, Robert G Cumming, Ian D Cameron, et al.
Journal of the American Geriatrics Society|May 5, 2011
Associations between drug burden index and falls in older people in residential aged careNicholas M Wilson, Sarah N Hilmer, Lyn M March, et al.
The Journal of Rheumatology|September 10, 2009
Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9John R Kirwan, Stanton Newman, Peter S Tugwell, et al.
Annals of the Rheumatic Diseases|February 20, 2014
The global burden of musculoskeletal conditions for 2010: an overview of methodsDamian G Hoy, Emma Smith, Marita Cross, et al.
Annals of the Rheumatic Diseases|July 2, 2020
Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working GroupSabrina Mai Nielsen, Helene Storgaard, Torkell Ellingsen, et al.
The Journal of Rheumatology|February 3, 2019
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT MethodologyDorcas E Beaton, Lara J Maxwell, Beverley J Shea, et al.
The Journal of Rheumatology|May 3, 2017
An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working GroupMonika E Finger, Annelies Boonen, Thasia G Woodworth, et al.
The Journal of Rheumatology|August 3, 2017
Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument SetsSean R Tunis, Lara J Maxwell, Ian D Graham, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Calcified Tissue International|November 26, 2010
Contribution of a common variant in the promoter of the 1-α-hydroxylase gene (CYP27B1) to fracture risk in the elderlyRoderick J Clifton-Bligh, Tuan V Nguyen, Amy Au, et al.
Age and Ageing|July 10, 2003
Proxy assessment of health-related quality of life in the frail elderlyYih Yiow Sitoh, Tang Ching Lau, Jane Zochling, et al.
Journal of the American Geriatrics Society|August 5, 2005
Atypical antipsychotic medications and risk of falls in residents of aged care facilitiesLe T T Hien, Robert G Cumming, Ian D Cameron, et al.
Journal of the American Geriatrics Society|May 5, 2011
Associations between drug burden index and falls in older people in residential aged careNicholas M Wilson, Sarah N Hilmer, Lyn M March, et al.
The Journal of Rheumatology|September 10, 2009
Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9John R Kirwan, Stanton Newman, Peter S Tugwell, et al.
Annals of the Rheumatic Diseases|February 20, 2014
The global burden of musculoskeletal conditions for 2010: an overview of methodsDamian G Hoy, Emma Smith, Marita Cross, et al.
Annals of the Rheumatic Diseases|July 2, 2020
Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working GroupSabrina Mai Nielsen, Helene Storgaard, Torkell Ellingsen, et al.
The Journal of Rheumatology|February 3, 2019
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT MethodologyDorcas E Beaton, Lara J Maxwell, Beverley J Shea, et al.
The Journal of Rheumatology|May 3, 2017
An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working GroupMonika E Finger, Annelies Boonen, Thasia G Woodworth, et al.
The Journal of Rheumatology|August 3, 2017
Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument SetsSean R Tunis, Lara J Maxwell, Ian D Graham, et al.
Pageof 7